Newly-released Intravenous Infusion Pumps market analysis report by Persistence Market Research shows that global sales of the Intravenous Infusion Pumps Market in 2021 were held at US$ 5.2 Bn. With a CAGR of 9% during 2022 – 2032, the market is projected to reach a valuation of US$ 13.2 Bn.The absolute dollar opportunity for Intravenous Infusion Pumps Market will be witnessing US$ 7.6 Bn overall growth because the demand for intravenous infusion pumps in healthcare facilities such as hospitals, and nursing homes have significantly increased.
The global intravenous infusion pumps market has been witnessing significant growth and is expected to continue expanding in the coming years. Intravenous infusion pumps are crucial medical devices that are widely used in various healthcare settings to administer fluids, medication, or nutrients directly into a patient’s bloodstream. The market is driven by several key factors:
Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has led to a greater need for advanced drug delivery systems, thereby driving the demand for intravenous infusion pumps.
Growing Geriatric Population: With a globally expanding elderly population, there is an increased requirement for efficient and accurate infusion systems to cater to the specific healthcare needs of this demographic.
Technological Advancements: Ongoing advancements in healthcare technology, including the development of smart pumps, wireless connectivity, and the integration of advanced features for personalized medicine, are fueling market growth.
Increased Focus on Home Healthcare: There is a growing trend towards home-based healthcare services, leading to a rise in the adoption of portable and user-friendly infusion pumps that enable patients to receive treatment in the comfort of their homes.
Demand for Minimally Invasive Therapies: The preference for minimally invasive procedures among both patients and healthcare providers is driving the demand for infusion pumps that can accurately and precisely administer medications and fluids.
Key players in the market include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Fresenius SE & Co. KGaA, and ICU Medical, Inc., among others. These companies are actively involved in product development, strategic collaborations, and mergers and acquisitions to strengthen their market presence and expand their product portfolios.
The growth of the global intravenous infusion pumps market is influenced by several key factors that contribute to its expansion and development. These growth factors include:
Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, has led to a growing demand for intravenous therapy, thereby driving the need for advanced and efficient infusion pumps.
Technological Advancements: Continuous advancements in technology, including the development of smart pumps, integration of software and wireless connectivity, and the introduction of innovative features such as dose error reduction systems (DERS), have enhanced the safety, accuracy, and efficiency of intravenous infusion pumps, contributing to market growth.
Rising Demand for Home Healthcare: The increasing preference for home healthcare services has led to a surge in demand for portable and easy-to-use infusion pumps, allowing patients to receive treatment in the comfort of their homes. This trend has significantly contributed to the expansion of the market.
Growing Geriatric Population: The global increase in the elderly population has led to a greater need for healthcare services, including infusion therapy, driving the demand for intravenous infusion pumps designed to cater to the specific requirements of the elderly population.
Demand for Minimally Invasive Procedures: The growing preference for minimally invasive treatment options has increased the adoption of intravenous infusion pumps, as they enable the precise and controlled delivery of medications and fluids, minimizing the risk of complications and improving patient outcomes.
Focus on Value-based Healthcare: The shift towards value-based healthcare, emphasizing improved patient outcomes and cost-effective treatments, has accelerated the adoption of advanced medical devices such as intravenous infusion pumps, which contribute to the efficient delivery of medications and fluids.
Increasing Healthcare Expenditure: The continuous growth in healthcare spending, especially in emerging economies, has facilitated the adoption of advanced medical technologies, including intravenous infusion pumps, thereby driving market growth and expansion.
Understanding these growth factors is essential for market players to develop effective strategies, invest in research and development, and introduce innovative products to capitalize on the opportunities presented by the expanding intravenous infusion pumps market.
You Can Customize this Report As per Your Requirement Click Here@ https://www.persistencemarketresearch.com/request-customization/33220
Market Challenges :
The global market for intravenous infusion pumps faces several challenges that can impact its growth and development. These challenges include:
Stringent Regulatory Compliance: The market is subject to stringent regulatory standards and compliance requirements, which can increase the time and cost associated with obtaining regulatory approvals for new products and may pose barriers to entry for smaller companies.
Product Recalls and Safety Concerns: Issues related to the safety and reliability of infusion pumps, including product recalls, device malfunctions, and adverse events, can lead to a loss of consumer confidence, negatively impacting market growth.
High Cost of Equipment: The initial high cost associated with the purchase and maintenance of intravenous infusion pumps may limit their adoption, particularly in healthcare facilities with limited financial resources, thereby hindering market growth.
Technological Complexities: Complexities associated with the integration and operation of technologically advanced infusion pumps can pose challenges for healthcare providers, leading to potential operational inefficiencies and a need for extensive training.
Limitations in Emerging Markets: Limited healthcare infrastructure, lack of awareness about advanced medical devices, and economic constraints in emerging markets may restrict the adoption of intravenous infusion pumps, affecting market expansion in these regions.
Competitive Market Landscape: The presence of several established market players, along with intense competition, can pose challenges for new entrants and smaller companies attempting to gain market share, leading to pricing pressures and limited differentiation.
Data Security and Privacy Concerns: With the increasing integration of digital features and connectivity in infusion pumps, concerns regarding data security and patient privacy have emerged, necessitating the implementation of robust cybersecurity measures and compliance with data protection regulations.
Addressing these challenges requires industry stakeholders to invest in research and development to improve product safety, efficiency, and cost-effectiveness, as well as to focus on regulatory compliance, training, and customer education initiatives to enhance the adoption of intravenous infusion pumps in healthcare settings.
Which Country Lies at the Centerstage for Intravenous Infusion Pumps market Revenue?
The United States dominated the global Intravenous Infusion Pumps Market and is expected to reach US$ 5.3 Bn by 2032. The reimbursement and technological advancement facilities are advantageous factors in the United States are some of the key factors propelling the demand.
The growing geriatric population is a key driver of market expansion in the country. According to US Census Bureau projections, the number of Americans aged 65 and above is expected to grow from 52 million in 2018 to nearly 95 million by 2060. Furthermore, the proportion of the population aged 65 and above is expected to rise from 16% to 23%.
Because of the increased prevalence of chronic illnesses, expanding geriatric population, and advantageous reimbursement policies in this area, North America is likely to have a significant market share in the intravenous infusion pumps market. Chronic illnesses account for more than 75% of all healthcare expenses in the United States, according to the Centers for Disease Control and Prevention and the National Center for Health Statistics.
Which Intravenous Infusion Pumps Captures Highest Demand?
Insulin infusion pumps which account for over one-fifth of the demand are expected to grow at a 10.8% CAGR. According to the International Diabetes Federation (IDF), roughly 463 million persons worldwide have diabetes in 2019, with the figure expected to rise to 700 million by 2045. With the rising incidence of diabetes, equipment like insulin infusion pumps is becoming increasingly useful for those who self-administer insulin on a regular basis.
An insulin pump is a compact electronic device that delivers continuous brief insulin through a thin tube, eliminating the need for long-acting insulin. A continuous insulin infusion also eliminates the need for repeated daily injections.
Smart pumps enabled with error-prevention software and controlled IV medication are significantly used as these intravenous pumps are equipped with advanced features. The smart pumps provide drug libraries, which help with the storage of the actual volume of fluid given to the patient, and barcode scanning technology, which aids in verifying a patient’s identity as well as avoiding medication administration errors.
The global market for intravenous infusion pumps faces several restraints that could impede its growth and development. These restraints include:
High Maintenance Costs: Intravenous infusion pumps require regular maintenance and servicing to ensure their proper functioning. The associated costs of maintenance and servicing can be significant, posing a financial burden for healthcare facilities and limiting the adoption of these devices.
Concerns Regarding Device Compatibility: Integration issues and compatibility concerns with different types of medication and fluids can restrict the widespread adoption of intravenous infusion pumps, particularly in complex healthcare environments with diverse patient needs.
Limited Reimbursement Policies: Inadequate or limited reimbursement policies for intravenous infusion pumps and associated services in certain regions can discourage healthcare providers from investing in these devices, affecting market growth.
Risk of Medication Errors: Despite technological advancements, the risk of medication errors associated with the use of intravenous infusion pumps remains a concern. Improper programming or configuration of the pumps can lead to adverse patient outcomes and safety issues, potentially restraining market growth.
Inadequate Awareness and Training: Insufficient awareness among healthcare professionals about the benefits and proper usage of intravenous infusion pumps, coupled with inadequate training programs, can hinder their effective adoption and utilization in healthcare settings.
Limitations in Emerging Economies: In emerging economies, limited healthcare infrastructure, budgetary constraints, and a lack of skilled healthcare professionals can act as significant restraints for the adoption of advanced medical devices, including intravenous infusion pumps.
Concerns Regarding Patient Safety and Comfort: Patient discomfort, the risk of infections, and the potential for adverse reactions associated with the use of intravenous infusion pumps may lead to a reluctance among healthcare providers and patients, thereby restraining market growth.
Over the projected period, rising emphasis on innovations and investments among public and private entities is expected to strengthen competition in the market. The key vendors in the global Intravenous Infusion Pumps market are Baxter International, B. Braun Melsungen, AG Medtronic, Micrel Medical Devices, SA Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, and Smiths Medical among others.
Some of the recent development in the Intravenous Infusion Pumps Market are:
- In April 2021, Medtronic announced the availability of its extended infusion set in several European countries. This infusion set may be worn for 7 days, allowing diabetic patients to continue intravenous infusion pump therapy with fewer insertions and interruptions.
- In August 2020, Mindray released a new generation infusion system called the BeneFusion n Series. It provides significant insights into patient safety, interoperability and data management, and operational simplicity, all of which contribute to the establishment of new standards in infusion treatment.
Market Segments Covered in Intravenous Infusion Pumps Industry Analysis
By Infusion Pumps Type
Volumetric Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Enteral Infusion Pumps
Ambulatory Infusion Pumps
Patient-Controlled Analgesia Infusion Pumps
Implantable Infusion Pumps
Other Infusion Pumps Types
By Disease Indication
Other Disease Indications
Industrial Automation and Control System Market: https://articlescad.com/industrial-automation-and-control-system-market-to-witness-robust-expansion-throughout-the-forecast-9897.html
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on micros by Persistence Market Research helps companies overcome their macro business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies/clients shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Persistence Market Research
Teerth Technospace, Unit B-704
Survey Number 103, Baner
Mumbai Bangalore Highway
Pune 411045 India